Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
94.45
+0.62 (0.66%)
At close: Dec 20, 2024, 4:00 PM
96.00
+1.55 (1.64%)
Pre-market: Dec 23, 2024, 4:13 AM EST
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 106.75, with a low estimate of 95 and a high estimate of 117. The average target predicts an increase of 13.02% from the current stock price of 94.45.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 30, 2024.
Analyst Ratings
The average analyst rating for EHC stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 3 | 3 | 3 |
Buy | 5 | 3 | 3 | 5 | 5 | 5 |
Hold | 1 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +16.46% | Oct 30, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | +22.82% | Oct 30, 2024 |
Barclays | Barclays | Buy Maintains $109 → $116 | Buy | Maintains | $109 → $116 | +22.82% | Oct 29, 2024 |
Keybanc | Keybanc | Buy Maintains $115 → $117 | Buy | Maintains | $115 → $117 | +23.88% | Oct 29, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $104 → $108 | Strong Buy | Maintains | $104 → $108 | +14.35% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
5.40B
from 4.80B
Increased by 12.53%
Revenue Next Year
5.90B
from 5.40B
Increased by 9.12%
EPS This Year
4.33
from 3.47
Increased by 24.56%
EPS Next Year
4.82
from 4.33
Increased by 11.38%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 5.6B | 6.3B | 6.8B |
Avg | 5.4B | 5.9B | 6.4B |
Low | 5.2B | 5.6B | 6.1B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 17.3% | 15.9% | 15.8% |
Avg | 12.5% | 9.1% | 8.6% |
Low | 8.8% | 4.4% | 3.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.58 | 5.51 | 6.35 | ||
Avg | 4.33 | 4.82 | 5.35 | ||
Low | 4.14 | 4.33 | 4.68 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 31.7% | 27.4% | 31.8% | ||
Avg | 24.6% | 11.4% | 11.0% | ||
Low | 19.0% | 0.1% | -2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.